| 000 | 01228 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250512213552.0 | ||
| 264 | 0 | _c19840820 | |
| 008 | 198408s 0 0 eng d | ||
| 022 | _a0160-6689 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSheehan, D V | |
| 245 | 0 | 0 |
_aDelineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification. _h[electronic resource] |
| 260 |
_bThe Journal of clinical psychiatry _cJul 1984 |
||
| 300 |
_a29-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAlprazolam |
| 650 | 0 | 4 |
_aAnxiety Disorders _xclassification |
| 650 | 0 | 4 |
_aBenzodiazepines _xtherapeutic use |
| 650 | 0 | 4 | _aBupropion |
| 650 | 0 | 4 |
_aDepressive Disorder _xdrug therapy |
| 650 | 0 | 4 | _aDexamethasone |
| 650 | 0 | 4 |
_aFear _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrocortisone _xblood |
| 650 | 0 | 4 | _aManuals as Topic |
| 650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPanic _xdrug effects |
| 650 | 0 | 4 |
_aPhobic Disorders _xclassification |
| 650 | 0 | 4 |
_aPropiophenones _xtherapeutic use |
| 650 | 0 | 4 | _aTerminology as Topic |
| 773 | 0 |
_tThe Journal of clinical psychiatry _gvol. 45 _gno. 7 Pt 2 _gp. 29-36 |
|
| 999 |
_c6429014 _d6429014 |
||